Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis C

  Free Subscription


Articles published in Ann Intern Med

Retrieve available abstracts of 42 articles:
HTML format
Text format



Single Articles


    May 2018
  1. NAKAMURA H, Fujieda Y, Yasuda S, Nakai M, et al
    Remission of Nephrotic Syndrome After Therapy for Chronic Hepatitis C Virus Infection in a Patient With Systemic Lupus Erythematosus.
    Ann Intern Med. 2018 May 1. pii: 2680058. doi: 10.7326/L17-0759.
    PubMed     Text format    


  2. BELPERIO PS, Chartier M, Ross DB
    After Curing Hepatitis C Virus Infection.
    Ann Intern Med. 2018;168:682-683.
    PubMed     Text format    


  3. DEBES JD
    After Curing Hepatitis C Virus Infection.
    Ann Intern Med. 2018;168:682.
    PubMed     Text format    


    March 2018
  4. EMMANUEL B, Masur H, Kottilil S, Kattakuzhy S, et al
    Expansion of Treatment for Hepatitis C Virus Infection.
    Ann Intern Med. 2018;168:457-459.
    PubMed     Text format    


  5. ROMANO MJ
    Expansion of Treatment for Hepatitis C Virus Infection.
    Ann Intern Med. 2018;168:456-457.
    PubMed     Text format    


  6. KATAREY D
    Expansion of Treatment for Hepatitis C Virus Infection.
    Ann Intern Med. 2018;168:457.
    PubMed     Text format    


  7. DURAND CM, Bowring MG, Brown DM, Chattergoon MA, et al
    Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus-Infected Donors to Noninfected Recipients: An Open-Label Nonrandomized Trial.
    Ann Intern Med. 2018 Mar 6. pii: 2674335. doi: 10.7326/M17-2871.
    PubMed     Text format     Abstract available


    January 2018
  8. ENOMOTO M, Tateishi C, Tsuruta D, Tamori A, et al
    Remission of Psoriasis After Treatment of Chronic Hepatitis C Virus Infection With Direct-Acting Antivirals.
    Ann Intern Med. 2018 Jan 16. pii: 2669850. doi: 10.7326/L17-0613.
    PubMed     Text format    


    November 2017
  9. BERSOFF-MATCHA SJ, Cao K, Jason M, Jones SC, et al
    Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus.
    Ann Intern Med. 2017;167:760.
    PubMed     Text format    


  10. MAHALE P, Glenn JS, O'Brien TR
    Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus.
    Ann Intern Med. 2017;167:759-760.
    PubMed     Text format    


    October 2017
  11. LOK AS, Chung RT, Vargas HE, Kim AY, et al
    Benefits of Direct-Acting Antivirals for Hepatitis C.
    Ann Intern Med. 2017 Oct 17. doi: 10.7326/M17-1876.
    PubMed     Text format    


  12. BELPERIO PS, Chartier M, Ross DB, Alaigh P, et al
    Curing Hepatitis C Virus Infection: Best Practices From the U.S. Department of Veterans Affairs.
    Ann Intern Med. 2017;167:499-504.
    PubMed     Text format     Abstract available


    August 2017
  13. KATTAKUZHY S, Gross C, Emmanuel B, Teferi G, et al
    Expansion of Treatment for Hepatitis C Virus Infection by Task Shifting to Community-Based Nonspecialist Providers: A Nonrandomized Clinical Trial.
    Ann Intern Med. 2017 Aug 8. doi: 10.7326/M17-0118.
    PubMed     Text format     Abstract available


  14. SCHVARTSMAN G, Perez K, Sood G, Katkhuda R, et al
    Immune Checkpoint Inhibitor Therapy in a Liver Transplant Recipient With Melanoma.
    Ann Intern Med. 2017 Aug 1. doi: 10.7326/L17-0187.
    PubMed     Text format    


    July 2017
  15. SACKS HS
    Review: In chronic hepatitis C virus infection, oral direct-acting antivirals have high sustained virologic response.
    Ann Intern Med. 2017;167:JC3.
    PubMed     Text format    


    June 2017
  16. KANDATHIL AJ, Breitwieser FP, Sachithanandham J, Robinson M, et al
    Presence of Human Hepegivirus-1 in a Cohort of People Who Inject Drugs.
    Ann Intern Med. 2017 Jun 6. doi: 10.7326/M17-0085.
    PubMed     Text format     Abstract available


  17. GRAHAM CS
    Making Do With What We Have.
    Ann Intern Med. 2017;166:850-851.
    PubMed     Text format    


    May 2017
  18. LY KN, Jiles RB, Teshale EH, Foster MA, et al
    Hepatitis C Virus Infection Among Reproductive-Aged Women and Children in the United States, 2006 to 2014.
    Ann Intern Med. 2017 May 9. doi: 10.7326/M16-2350.
    PubMed     Text format     Abstract available


  19. JR AD
    Hearing From the Silent Epidemic.
    Ann Intern Med. 2017 May 9. doi: 10.7326/M17-0927.
    PubMed     Text format    


    April 2017
  20. TALAL AH, Thomas DL, Reynolds JL, Khalsa JH, et al
    Toward Optimal Control of Hepatitis C Virus Infection in Persons With Substance Use Disorders.
    Ann Intern Med. 2017 Apr 25. doi: 10.7326/M16-2887.
    PubMed     Text format    


  21. BERSOFF-MATCHA SJ, Cao K, Jason M, Ajao A, et al
    Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event Reporting System.
    Ann Intern Med. 2017 Apr 25. doi: 10.7326/M17-0377.
    PubMed     Text format     Abstract available


  22. BUCKLEY GJ, Strom BL
    A National Strategy for the Elimination of Viral Hepatitis Emphasizes Prevention, Screening, and Universal Treatment of Hepatitis C.
    Ann Intern Med. 2017 Apr 4. doi: 10.7326/M17-0766.
    PubMed     Text format    


    March 2017
  23. HOOFNAGLE JH, Sherker AH
    Hepatitis C: Down but Not Out.
    Ann Intern Med. 2017 Mar 21. doi: 10.7326/M17-0567.
    PubMed     Text format    


  24. FALADE-NWULIA O, Suarez-Cuervo C, Nelson DR, Fried MW, et al
    Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review.
    Ann Intern Med. 2017 Mar 21. doi: 10.7326/M16-2575.
    PubMed     Text format     Abstract available


  25. DI BIASE L, Picillo M, Freitas ME, Bui E, et al
    Hepatitis C Virus-Related Hepatic Myelopathy After Treatment With Sofosbuvir and Ribavirin: A Case Report.
    Ann Intern Med. 2017;166:379-380.
    PubMed     Text format    


    November 2016
  26. COLOMBO M, Aghemo A, Liu H, Zhang J, et al
    Treatment With Ledipasvir-Sofosbuvir for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic Hepatitis C Virus Genotype 1 or 4 Infection: A Randomized Trial.
    Ann Intern Med. 2016 Nov 15. doi: 10.7326/M16-1205.
    PubMed     Text format     Abstract available


    October 2016
  27. WANG Q, De Luca A, Smith C, Zangerle R, et al
    Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients: A Cohort Study.
    Ann Intern Med. 2016 Oct 18. doi: 10.7326/M16-0240.
    PubMed     Text format     Abstract available


    September 2016
  28. KIM A
    Hepatitis C Virus.
    Ann Intern Med. 2016;165:ITC33-ITC48.
    PubMed     Text format     Abstract available


    August 2016
  29. DORE GJ, Altice F, Litwin AH, Dalgard O, et al
    Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial.
    Ann Intern Med. 2016 Aug 9. doi: 10.7326/M16-0816.
    PubMed     Text format     Abstract available


    June 2016
  30. FREIMAN JM, Tran TM, Schumacher SG, White LF, et al
    Hepatitis C Core Antigen Testing for Diagnosis of Hepatitis C Virus Infection: A Systematic Review and Meta-analysis.
    Ann Intern Med. 2016 Jun 21. doi: 10.7326/M16-0065.
    PubMed     Text format     Abstract available


    April 2016
  31. BUCKLEY GJ, Strom BL
    What Stands in the Way of Making Hepatitis B and C Rare Diseases in the United States?
    Ann Intern Med. 2016 Apr 12. doi: 10.7326/M16-0772.
    PubMed     Text format    


    February 2016
  32. MCCANCE-KATZ EF, Valdiserri RO
    Hepatitis C Virus Treatment and Persons Who Inject Drugs.
    Ann Intern Med. 2016;164:203-4.
    PubMed     Text format    


  33. GREBELY J, Dore GJ, Greenwald R, Swan T, et al
    Hepatitis C Virus Treatment and Persons Who Inject Drugs.
    Ann Intern Med. 2016;164:203.
    PubMed     Text format    


    November 2015
  34. KOHLI A, Kattakuzhy S, Sidharthan S, Nelson A, et al
    Four-Week Direct-Acting Antiviral Regimens in Noncirrhotic Patients With Hepatitis C Virus Genotype 1 Infection: An Open-Label, Nonrandomized Trial.
    Ann Intern Med. 2015 Nov 24:899-907. doi: 10.7326/M15-0642.
    PubMed     Text format     Abstract available


  35. HE T, Li K, Roberts MS, Spaulding AC, et al
    Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons.
    Ann Intern Med. 2015 Nov 24. doi: 10.7326/M15-0617.
    PubMed     Text format     Abstract available


  36. PIANKO S, Flamm SL, Shiffman ML, Kumar S, et al
    Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection: A Randomized Trial.
    Ann Intern Med. 2015 Nov 10. doi: 10.7326/M15-1014.
    PubMed     Text format     Abstract available


  37. EVERSON GT, Towner WJ, Davis MN, Wyles DL, et al
    Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection: A Randomized Trial.
    Ann Intern Med. 2015 Nov 10. doi: 10.7326/M15-1000.
    PubMed     Text format     Abstract available


    August 2015
  38. COTTON D
    Celebrating the ACP Centennial: From the Annals Archive-Non-A, Non-B Hepatitis.
    Ann Intern Med. 2015;163:315.
    PubMed     Text format    


    June 2015
  39. ONOFREY S, Aneja J, Haney GA, Nagami EH, et al
    Underascertainment of Acute Hepatitis C Virus Infections in the U.S. Surveillance System: A Case Series and Chart Review.
    Ann Intern Med. 2015 Jun 30. doi: 10.7326/M14-2939.
    PubMed     Text format     Abstract available


  40. CANARY LA, Klevens RM, Holmberg SD
    Limited Access to New Hepatitis C Virus Treatment Under State Medicaid Programs.
    Ann Intern Med. 2015 Jun 30. doi: 10.7326/M15-0320.
    PubMed     Text format    


  41. BARUA S, Greenwald R, Grebely J, Dore GJ, et al
    Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States.
    Ann Intern Med. 2015 Jun 30. doi: 10.7326/M15-0406.
    PubMed     Text format     Abstract available


  42. MCCANCE-KATZ EF, Valdiserri RO
    Hepatitis C Virus Treatment and Injection Drug Users: It Is Time to Separate Fact From Fiction.
    Ann Intern Med. 2015 Jun 30. doi: 10.7326/M15-0007.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: